Dr. Gill is a Co-Founder and Scientific Advisor for Cellvation and has been involved in the scientific and experimental development of Cellvation’s pipeline technology since its inception.  He is an Associate Professor of Surgery in the McGovern Medical School at UTHealth, and is the Director of Surgical Critical Care and Vice-Chief of Surgery at Lyndon B. Johnson General Hospital in Houston.  He is also a co-founder of EMIT Corporation and Coagulex, Inc., both of which arose from his research at UTHealth.  He holds a Bachelor’s degree in Biomedical Engineering from Harvard University and an M.D. from The University of Alabama.  He is Board Certified in General Surgery, Trauma Surgery and Critical Care.